Splicing factor SRSF1 is essential for CD8 T cell function and host antigen-specific viral immunity.

Autor: Juarez I; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Department of Immunology, Ophthalmology and ENT, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain., Su S; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.; Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Herbert ZT; Molecular Biology Core Facilities at Dana-Farber Cancer Institute, Boston, MA, United States., Teijaro JR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States., Moulton VR; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Sep 16; Vol. 13, pp. 906355. Date of Electronic Publication: 2022 Sep 16 (Print Publication: 2022).

Estrogen-Induced hsa-miR-10b-5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down-Regulates Serine/Arginine-Rich Splicing Factor 1.

Autor: Ramanujan SA; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, and Harvard College, Cambridge, Massachusetts., Cravens EN; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Krishfield SM; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Kyttaris VC; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Moulton VR; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Nov; Vol. 73 (11), pp. 2052-2058. Date of Electronic Publication: 2021 Sep 29.

Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.

Autor: Jamaly S; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Department of Medical Biology, Faculty of Health Science, UiT Arctic University of Norway, N-9037 Tromsø, Norway., Tsokos MG; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Bhargava R; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Brook OR; Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Hecht JL; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Abdi R; Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Moulton VR; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Satyam A; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address: asatyam@bidmc.harvard.edu., Tsokos GC; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Publikováno v: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2021 Aug; Vol. 229, pp. 108795. Date of Electronic Publication: 2021 Jul 10.

Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19.

Autor: Satyam A; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address: asatyam@bidmc.harvard.edu., Tsokos MG; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Brook OR; Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Hecht JL; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Moulton VR; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Tsokos GC; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Publikováno v: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2021 May; Vol. 226, pp. 108716. Date of Electronic Publication: 2021 Mar 24.

Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients: Results from a cross-sectional analysis.

Autor: Ceccarelli, Fulvia¹ (AUTHOR) fulviaceccarelli@gmail.com, Ciancarella, Claudia¹ (AUTHOR), Pirone, Carmelo¹ (AUTHOR), Natalucci, Francesco¹ (AUTHOR), Picciariello, Licia¹ (AUTHOR), Garufi, Cristina¹ (AUTHOR), Mancuso, Silvia¹ (AUTHOR), Truglia, Simona¹ (AUTHOR), Spinelli, Francesca Romana¹ (AUTHOR), Alessandri, Cristiano¹ (AUTHOR), Cont, Fabrizio¹ (AUTHOR)

Publikováno v: Lupus. Dec2024, Vol. 33 Issue 14, p1584-1593. 10p.